Rapid purification of Bordetella pertussis fimbria 2, 3 proteins and their immunogenicities;Bordetella pertussis fi̇mbri̇ya 2, 3 protei̇nleri̇ni̇n hizli saflaştirilmasi ve i̇mmünojeni̇tesi̇

Mikrobiyoloji Bulteni

Volumn 41, Issue 1, 2007, Pages 11-20

  Atakan Ablay, Pinar ^a   Özcengiz, Erkan ^a  

^a Aşi Serum Üretim ve Araştirma Bölümü ^*  (Turkey)

Author keywords

Bordetella pertussis; Fimbria; Pertussis vaccine

Indexed keywords

BACTERIAL ANTIGEN; FIMBRIA PROTEIN; MONOCLONAL ANTIBODY;

AGGLUTINATION TEST; ANIMAL; ARTICLE; BORDETELLA PERTUSSIS; CHEMISTRY; FIMBRIA; GEL CHROMATOGRAPHY; IMMUNOBLOTTING; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOUSE; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

AGGLUTINATION TESTS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BLOTTING, WESTERN; BORDETELLA PERTUSSIS; CHROMATOGRAPHY, GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIMBRIAE PROTEINS; FIMBRIAE, BACTERIAL; IMMUNOBLOTTING; MICE;

EID: 34748914389     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cassiday P, Sander C, Heuvelman K, Mooi F, Bisgard KM, Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis 2000; 182: 1402-8.
2. Van Loo IH, Mooi FR. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. Microbiology 2002; 148: 2011-8.
3. Sato Y, Arai H, Suzuki K. Leukocytosis-promoting factor of Bordetella pertussis. Infect Immun 1972; 6: 899-904.
4. Irons LI, Ashworth LA, Robinson A. Release and purification of fimbriae from Bordetella pertussis. Dev Biol Stand 1984; 61: 153-63.
5. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
6. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
7. Burns EH, Norman JM, Hatcher MD, Bemis DA. Fimbriae and determination of host species specificity of Bordetella bronchiseptica. J Clin Microbiol 1993; 31: 1838-44.
8. Al-Shakhshir RH, Regnier FE, White JL, Hem SL. Contribution of electrostatic and hydrophobic interactions to the adsorbtion of proteins by aluminium-containing adjuvants. Vaccine 1995; 13: 41-4.
9. Rose NR, Friedman H, Fahey JL. Manual of Clinical Laboratory Immunology, pp: 388-394. 1986, 3rd ed. American Society for Microbiology. Washington DC.
10. Carter EJ, Preston NW. Association between Bordetella pertussis agglutinogen 2 and fimbriae. J Med Microbiol 1984; 18: 87-94.
11. Preston NW. Essential immunogens in human pertussis: the role of fimbriae. Dev Biol Stand 1984; 61: 137-41.
12. Schleiss MR, Dahl K. Acellular pertussis vaccines. Curr Probl Pediatr 2000; 30: 181-201.
13. Ashworth LA, Irons LI, Dowsett AB. Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis. Infect Immun 1982; 37: 1278-81.
14. Zhang JM, Cowell JL, Steven AC, Manclark CR. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. Dev Biol Stand 1984; 61: 173-85.
15. Zhang JM, Cowell JL, Steven AC, Carter PH, McGrath PP, Manclark CR. Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect Immun 1985; 48: 422-7.
16. Li ZM, Brennan MJ, David JL, Carter PH, Cowell JL, Manclark CR. Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun 1988; 56: 3184-8.